Migraine Linked to Skull Bone Marrow Immune Activity

A Massachusetts General Hospital study links immune cell activity in the skull's bone marrow to how often people get migraines.

Updated on Nov. 19, 2026 in Diseases

Photograph of the open circular bore of a PET imaging scanner in a bright clinical room with coiled cabling on the floor.
Researchers at Massachusetts General Hospital tied immune cell activity in the skull's bone marrow to how often people experience migraines, in a study of 60 adults. AI Illustration. Upload story photo >

Live Poll

Do you trust medical researchers to find better migraine treatments?

Researchers at Massachusetts General Hospital found altered immune cell activity in the skull's bone marrow linked to migraine frequency. The study, published November 13 in The Lancet Medical Imaging & Theranostics, enrolled 60 adults with migraine and nine healthy controls.

Why it matters

The findings point to a possible role for inflammatory processes in the skull and adjacent membranes in migraine, which prior imaging had hinted at. Understanding these immune pathways could inform future research into how migraines develop and persist.

The study used a PET/MRI scanner with the radiotracer carbon-11 PBR28 across 90-minute continuous scans of participants reporting four to 20 headache days per month. Whether these immune signals drive migraine or result from it has not been determined.

The players

Massachusetts General Hospital

A major Boston teaching hospital affiliated with Harvard Medical School and known for its research across neurology and imaging.

The details

Researchers used the radiotracer carbon-11 PBR28, which binds to the 18-kDa translocator protein, a marker of immune cell density. The skull bone marrow signal was positively associated with migraine frequency and partly accounted for the relationship between migraine frequency and interleukin-16.

Timeline

  1. November 13, 2026: Study published in The Lancet Medical Imaging & Theranostics.

Big Picture

Earlier TSPO-PET imaging of migraine pointed to inflammation involving the skull or adjacent membranes, and this study extends that work by tying the signal in skull bone marrow to how often patients get headaches. The result suggests the immune component of migraine may sit outside the brain itself.

The findings do not yet change how migraines are diagnosed or treated, and no new therapy is available from this research. Readers with frequent migraines should continue working with their clinicians on established management options.

The takeaway

Immune activity outside the brain may contribute to migraine, opening a new avenue for future research. Larger studies will be needed before any clinical application can be considered.

Further reading

For more on neurological research, explore Alzheimer’s coverage in Boston.

Source note: This article includes information reported by AuntMinnie.

Live Poll

Do you trust medical researchers to find better migraine treatments?